Predictive factors for elevated prostate specific antigen and hematocrit levels during testosterone replacement therapy in patients with testosterone deficiency

Objective: We examined risk factors associated with prostate specific antigen (PSA) and hematocrit (hct) elevation during testosterone replacement therapy (TRT) in patients with testosterone deficiency (TD). Methods: We retrospectively analyzed the medical records of patients receiving TRT for ≥3 mo...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of Men's Health 2022-04, Vol.18 (4), p.1
Hauptverfasser:	Chung Heon Ryu, Sun Gu Park, Jeong Kyun Yeo, Min Gu Park
Format:	Artikel
Sprache:	eng
Schlagworte:	hematocrit prostate specific antigen (psa) testosterone testosterone deficiency testosterone replacement therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!